证券研究报告 美亚光电 (002690 CH) 看好新品带动盈利能力持续提升 | 华泰研究 | | | 年报点评 | 投资评级(维持): | 增持 | | --- | --- | --- | --- | --- | --- | | 2026 年 | 3 月 | 31 日│中国内地 | 专用设备 | 目标价(人民币): | 22.50 | 公司发布 25 年年报，收入 24 亿，同比+4%，归母净利润 7.2 亿，同比+11%， 其中 25Q4 单季度实现收入 7.1 亿，同比-3%，归母净利润 2 亿，同比+0.6%。 公司年报利润略微高于我们此前报告中 7.0 亿的预期，超出原因主要系下半 年毛利率有所提升。25 年公司色选机业务维持稳健增长，同时 CBCT 行业 竞争有所缓和，看好后续稳健的盈利表现和高分红属性，维持"增持"评级。 聚焦优质客户，色选机出海和产品升级带动 25 年收入增长 25Q4 公司收入同比-3%，较前三季度有所放缓，或主要来源于公司经营决 策调整、更为聚焦优质客户。全年公司色选机/医疗设备/工业检测收入分别 同比+8%/-10%/+3.5%。色选机方面，国内农产品色选市场已进入成熟稳 ...

Core Insights - The orthodontic industry is experiencing a dual drive from aesthetic economy and health necessities, with significant advancements in AI and consumer engagement [1][21] - The industry has evolved into a cross-sector involving high-end medical device manufacturing, digital healthcare services, and personalized consumption [1][21] Industry Chain Summary and Impact - The orthodontic industry chain is clearly defined, with a "smile curve" distribution, where the midstream digital treatment solution design and service platform is the core of value creation and profit center [3][22] - The upstream includes medical polymer materials (e.g., TPU, PETG for invisible aligners), metal alloys (brackets, archwires), digital equipment (intraoral scanners, CBCT, 3D printers), and design software suppliers [3][22] - The downstream consists of various dental service institutions, which are the final value realization and customer touchpoints, with changes in the downstream landscape influencing the upstream and midstream [3][22] Competitive Landscape - The current competition in the industry shows a distinct characteristic of "high concentration in midstream, decentralized but accelerating integration in downstream" [4][23] - The midstream invisible aligner solution market has formed a solid "duopoly" with Align Technology (Invisalign) and Angelalign dominating the market, holding a significant share [4][23] - The private market is represented by chain institutions like Tongce Medical and Ruier Group, which are expanding market share through standardized management and brand building [5][23] Technology Level and Characteristics - The industry is at a stage of comprehensive digitalization and burgeoning intelligence [6][24] - Digital technology has become the industry infrastructure, with 3D scanning replacing traditional silicone impressions, and CBCT widely used for three-dimensional assessments [7][25] - AI is rapidly penetrating and deepening its application, significantly enhancing design efficiency and reducing communication costs between doctors and technicians [8][26] Development Trends - AI is expected to evolve from "assisting" to "empowering" core functions, enhancing predictive capabilities and treatment plan adjustments [10][28] - The integration of treatment scenarios is expanding from "orthodontics" to "overall oral health management," creating new treatment combinations [11][29] - The trend towards affordability and market penetration is expected to activate a large incremental population, especially in lower-tier cities [12][30] - Leading companies are shifting from merely selling products to providing comprehensive solutions that enhance customer engagement and data value [13][31] - Chinese companies are accelerating their global expansion, establishing competitiveness in the digital orthodontics field [14][32]

Summary of Meiya Optoelectronics Conference Call Company Overview - **Company**: Meiya Optoelectronics - **Industry**: Medical Devices and Resource Recycling Key Points Financial Performance - In the first half of 2025, Meiya Optoelectronics reported a revenue growth of **10%** and a net profit increase of **11%** [3] - The color sorting machine segment showed a particularly strong performance with a **15%** growth in business and an improvement in gross margin [3] - The medical segment stabilized after a decline, with revenue remaining flat compared to the previous year, although gross margin decreased [3] Business Segments - The oral healthcare business revenue was approximately flat year-on-year, with a slight decline of **0.5%** [6] - The recycling resource business accounted for **20%** of the color sorting machine's total revenue, showing rapid growth in the first half of 2025 [15] - The overseas medical device business has registered in over **50** countries, achieving double-digit growth despite challenges [4][20] Strategic Initiatives - Meiya Optoelectronics is focused on enhancing core competitiveness and flexible marketing strategies to expand sales in the oral healthcare sector [9] - The company is leveraging AI and digital technologies to improve production efficiency and effectiveness, including the launch of the AI-powered Meiya Engine for oral CBCT [11] - The company plans to maintain a high dividend policy while investing **185 million yuan** in a new project, ensuring cash flow remains unaffected [4][25] Market Outlook - The company expects to maintain steady growth in the second half of 2025, despite potential pressures from market conditions [5] - The domestic oral healthcare industry is currently in a downturn, but Meiya Optoelectronics believes in a positive future driven by economic recovery and demographic trends [8][9] - The color sorting machine segment is anticipated to continue benefiting from increasing market demand and improved product competitiveness [23] Challenges and Responses - The domestic oral healthcare market faces intense competition and low pricing, but Meiya Optoelectronics is confident in its market position and risk resilience [8] - The company is committed to high-quality development and will not sacrifice margins for market share [9] Future Developments - The company is optimistic about the future of its mobile CT devices, which are in the early stages of market introduction [21] - Meiya Optoelectronics is evaluating its digital solutions for rice processing, which are expected to gain traction as the industry moves towards greater automation [13] Additional Insights - The gross margin for the recycling resource business is notably high, indicating strong profitability potential [19] - The company is actively working on enhancing its brand influence and service capabilities to compete effectively in the market [9] This summary encapsulates the key insights from the conference call, highlighting the company's performance, strategic initiatives, market outlook, and challenges faced in the current environment.

Investment Rating - The report maintains an "Accumulate" rating for the company with a target price of RMB 25.60 [6][7]. Core Views - The company has shown improvement in profit quality and is expected to benefit from a recovery in the industry [1]. - The color sorting machine business is experiencing rapid growth, while the revenue from dental medical equipment has reached a bottom [2]. - The gross profit margin for CBCT has rebounded, and the overall net profit margin has stabilized [3]. - There has been a significant improvement in cash flow, with net cash flow from operating activities increasing by 125% year-on-year [4]. - The company is optimistic about the growth potential of its color sorting machine business and the recovery of the CBCT business, maintaining profit forecasts for 2025 [5]. Summary by Sections Financial Performance - In H1 2025, the company achieved revenue of RMB 1.023 billion, a year-on-year increase of 9.92%, and a net profit of RMB 303 million, up 11.34% year-on-year [1]. - The gross profit margin for the first half of the year was 52.14%, with a net profit margin of 29.61%, reflecting a year-on-year increase of 1.26 percentage points and 0.38 percentage points, respectively [3]. Business Segments - The color sorting machine business saw a revenue increase of 15.2% year-on-year, while the medical equipment segment experienced a slight decline of 0.5% [2]. - The company has made significant strides in digital transformation within the dental medical sector, with over 10,000 users on its "Meiya Meiya" digital health platform by the end of June [2]. Cash Flow and Working Capital - The net cash flow from operating activities reached RMB 393 million, which is higher than the net profit, marking the first time since 2017 that this has occurred [4]. - Accounts receivable and inventory decreased year-on-year, indicating improved operational efficiency and industry leverage [4]. Profit Forecast and Valuation - The company forecasts net profits of RMB 700 million, RMB 744 million, and RMB 789 million for 2025, 2026, and 2027, respectively [5]. - The report assigns a PE ratio of 32 times for 2025, reflecting a target price adjustment based on comparable company valuations [5].